Pending.AI is developing AI solutions to empower scientists in the pharmaceutical industry to design, make, and test new drugs to treat diseases.

We are working on:
– De novo Drug Design 
– Synthesis Planning
– High-throughput Chemistry
– Structure-based Drug Design

AI models are trained across federated datasets that contain millions of data points in order to offer high-quality solutions. AI is becoming more essential as scientific data is becoming more abundant and more accessible. AI-based solutions are used by scientists and teams to assist them in making more informed decisions.


50+ exciting resident startups at iAccelerate span a wide variety of industries. Our residents are a mix of industry sectors and maturity.

View all residents